T Doi1, H Makizako, K Tsutsumimoto, R Hotta, S Nakakubo, K Makino, T Suzuki, H Shimada. 1. Takehiko Doi, Department of Preventive Gerontology, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, 7-430, Morioka, Obu, Aichi 474-8511, Japan, Tel.: +81-562-44-5651, Fax: +81-562-46-8294, E-mail: take-d@ncgg.go.jp.
Abstract
OBJECTIVES: Frailty is a course experienced in advanced aging. Identification of a biological factor associated with frailty is required. Although serum insulin-like growth factor-1 (IGF-1) is a potential factor related with frailty, consensus has not been reached regarding this relationship. This study aimed to investigate the association between IGF-1 and frailty in older adults. DESIGN: Cross-sectional study. SETTING: Cohort study that was part of the "National Center for Geriatrics and Gerontology - Study of Geriatric Syndromes." PARTICIPANTS: The study participants were 4133 older adults (mean age, 71.8 ± 5.4 years). MEASUREMENTS: We assessed serum IGF-1 levels and frailty status and collected demographic variables, including cognitive function, as covariates. RESULTS: Frailty and pre-frailty were present in 274 subjects (7%) and 1930 subjects (47%), respectively. Subjects were divided into four groups based on quartiles of IGF-1 levels. Multinomial logistic analysis showed that the lowest group had significant odds of pre-frailty (crude model: odds ratio [OR] 1.58, 95% confidence interval [CI] 1.30-1.90, p < .001; adjusted model: OR 1.38, 95% CI 1.13-1.68, p = .002) and frailty (crude model: OR 3.42, 95% CI 2.38-4.92, p < .001; adjusted model: OR 1.54, 95% CI 1.02-2.32, p = .039), compared with the highest group. CONCLUSION: Lower serum IGF-1 levels were independently related with frailty in older adults.
OBJECTIVES: Frailty is a course experienced in advanced aging. Identification of a biological factor associated with frailty is required. Although serum insulin-like growth factor-1 (IGF-1) is a potential factor related with frailty, consensus has not been reached regarding this relationship. This study aimed to investigate the association between IGF-1 and frailty in older adults. DESIGN: Cross-sectional study. SETTING: Cohort study that was part of the "National Center for Geriatrics and Gerontology - Study of Geriatric Syndromes." PARTICIPANTS: The study participants were 4133 older adults (mean age, 71.8 ± 5.4 years). MEASUREMENTS: We assessed serum IGF-1 levels and frailty status and collected demographic variables, including cognitive function, as covariates. RESULTS: Frailty and pre-frailty were present in 274 subjects (7%) and 1930 subjects (47%), respectively. Subjects were divided into four groups based on quartiles of IGF-1 levels. Multinomial logistic analysis showed that the lowest group had significant odds of pre-frailty (crude model: odds ratio [OR] 1.58, 95% confidence interval [CI] 1.30-1.90, p < .001; adjusted model: OR 1.38, 95% CI 1.13-1.68, p = .002) and frailty (crude model: OR 3.42, 95% CI 2.38-4.92, p < .001; adjusted model: OR 1.54, 95% CI 1.02-2.32, p = .039), compared with the highest group. CONCLUSION: Lower serum IGF-1 levels were independently related with frailty in older adults.
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: P S van Dam; A Aleman; W R de Vries; J B Deijen; E A van der Veen; E H de Haan; H P Koppeschaar Journal: Growth Horm IGF Res Date: 2000-04 Impact factor: 2.372
Authors: Laura D Baker; Suzanne M Barsness; Soo Borson; George R Merriam; Seth D Friedman; Suzanne Craft; Michael V Vitiello Journal: Arch Neurol Date: 2012-11
Authors: Andrew J Westwood; Alexa Beiser; Charles Decarli; Tamara B Harris; Tai C Chen; Xue-Mei He; Ronenn Roubenoff; Aleksandra Pikula; Rhoda Au; Lewis E Braverman; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri Journal: Neurology Date: 2014-04-04 Impact factor: 9.910